Table 2 Trends in surgically resected pancreatic cystic neoplasms
| Â | 1997-2000 | 2001-2004 | 2005-2008 | 2009-2013 |
|---|---|---|---|---|
N | 3 (2.7%) | 6 (5.4%) | 27 (24.3%) | 75 (67.6%) |
Symptoms, n (%) | Â | Â | Â | Â |
Yes | 2 (66.7%) | 4 (66.7%) | 17 (63.0%) | 39 (52.0%) |
No | 1 (33.3%) | 2 (33.3%) | 10 (37.0%) | 36 (48.0%) |
Time interval, months, median (range)* | 0.3 (0.2-12.0) | 1 (0.2-48.0) | 1 (0.1-120.0) | 1 (0.02-144.0) |
Pancreatic cystic neoplasms, n (%) | Â | Â | Â | Â |
IPMN (intraductal papillary mucinous neoplasm) | 0 | 0 | 5 (18.5%) | 12 (16.0%) |
MCN (mucinous cystic neoplasm) | 2 (66.7%) | 1 (16.7%) | 3 (11.1%) | 14 (18.7%) |
SCN (serous cystic neoplasm) | 1 (33.3%) | 1 (16.7%) | 15 (55.6%) | 22 (29.3%) |
SPN (solid pseudopapillary neoplasm) | 0 | 4 (66.7%) | 4 (14.8%) | 27 (36.0%) |